Europe
TFS International is thrilled with the announcement that Lecigon®, a new therapeutic system for symptomatic treatment of Advanced Parkinson’s Disease (APD), has been granted marketing authorization in Sweden.
Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation
Aglaris Ltd. today announced the appointment of Steven Docksey to the role of CEO of the Anglo-Spanish cell therapy equipment manufacturer, effective immediately.
Fast-emerging area of research with potential to treat severe diseases including cancer and autoimmune conditions
FDA issued a Complete Response letter to Acacia Pharma on Friday 5 October
pceth Biopharma GmbH congratulates its partner bluebird bio on the acceptance and validation of its market authorization application by the European Medicines Agency (EMA).
The ASSIST PLUS pipetting robot from INTEGRA Biosciences received a prestigious Basel Life MipTec Product Innovation Award 2018 at this year’s MipTec exhibition.
Hutchison China MediTech Limited today announces that it has appointed HSBC Bank plc as its joint Corporate Broker in London with immediate effect.
Probiodrug AG announced today that effective October 31, 2018, and with the contractual termination of her current agreement, Dr. Inge Lues’ term as Chief Development Officer will come to an end.
In a report, Bloomberg said that pharma’s “efforts to maximize (financial) gains” has led to the coloring of R&D decisions and creating barriers to the entry of competing medications that can add costs to the health care system.
PRESS RELEASES